Onos, ROMVIMZA

Ono's ROMVIMZA Approval Shakes Up Tenosynovial Giant Cell Tumors Market, Challenging Daiichi Sankyo's TURALIO Dominance | DelveInsight

07.08.2025 - 18:04:41

DelveInsight Business Research, LLP United States of America United Kingdom

@ prnewswire.co.uk